Literature DB >> 9773870

Standardizing flow cytometry: a classification system of fluorescence standards used for flow cytometry.

A Schwartz1, G E Marti, R Poon, J W Gratama, E Fernández-Repollet.   

Abstract

The growing number of standards commercially available in the field of flow cytometry makes it difficult to know which standards to use to obtain a desired level of quality assurance. A classification system of fluorescence standards has been developed on the basis of their physical characteristics. In turn, these physical characteristics determine the ability of the specific standards to perform selected functions, such as alignment, target referencing, compensation, and calibration. Knowing the properties and limitations of specific standards will help flow cytometer users to select the appropriate standard for the application that they will be performing, especially in regard to intra- and interlaboratory quality assurance. Common protocols used in conjunction with specific classifications of reference standards can provide unified analysis regions or window of analysis across different instruments and/or laboratories. In addition, specific classifications of calibration standards can help select those standards that will provide independent and direct comparison of instrument performance parameters, especially in studies involving multiple laboratories. Knowledge and understanding of the classification system can guide flow cytometer users in more efficient and accurate instrument setup and quality control when conducting research, as well as clinical applications.

Mesh:

Year:  1998        PMID: 9773870

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  19 in total

1.  A bead-based method for multiplexed identification and quantitation of DNA sequences using flow cytometry.

Authors:  A Spiro; M Lowe; D Brown
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Quantitative fluorescence measures for determination of intracellular perforin content.

Authors:  Kevin J Maher; Nancy G Klimas; Barry Hurwitz; Richard Schiff; Mary Ann Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Characterization of CD22 expression in acute lymphoblastic leukemia.

Authors:  Nirali N Shah; Maryalice Stetler Stevenson; Constance M Yuan; Kelly Richards; Cindy Delbrook; Robert J Kreitman; Ira Pastan; Alan S Wayne
Journal:  Pediatr Blood Cancer       Date:  2015-03-01       Impact factor: 3.167

4.  How to improve quality assurance in fluorometry: fluorescence-inherent sources of error and suited fluorescence standards.

Authors:  U Resch-Genger; K Hoffmann; W Nietfeld; A Engel; J Neukammer; R Nitschke; B Ebert; R Macdonald
Journal:  J Fluoresc       Date:  2005-05       Impact factor: 2.217

5.  Traceability in fluorometry: Part II. Spectral fluorescence standards.

Authors:  U Resch-Genger; D Pfeifer; C Monte; W Pilz; A Hoffmann; M Spieles; K Rurack; J Hollandt; D Taubert; B Schönenberger; P Nording
Journal:  J Fluoresc       Date:  2005-05       Impact factor: 2.217

6.  Genetic barcoding with fluorescent proteins for multiplexed applications.

Authors:  Cameron A Smurthwaite; Wesley Williams; Alexandra Fetsko; Darin Abbadessa; Zachary D Stolp; Connor W Reed; Andre Dharmawan; Roland Wolkowicz
Journal:  J Vis Exp       Date:  2015-04-14       Impact factor: 1.355

7.  Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

Authors:  Waleed Haso; Daniel W Lee; Nirali N Shah; Maryalice Stetler-Stevenson; Constance M Yuan; Ira H Pastan; Dimiter S Dimitrov; Richard A Morgan; David J FitzGerald; David M Barrett; Alan S Wayne; Crystal L Mackall; Rimas J Orentas
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

8.  Quality assurance for polychromatic flow cytometry using a suite of calibration beads.

Authors:  Stephen P Perfetto; David Ambrozak; Richard Nguyen; Pratip K Chattopadhyay; Mario Roederer
Journal:  Nat Protoc       Date:  2012-11-08       Impact factor: 13.491

9.  Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.

Authors:  Francis Mussai; Dario Campana; Deepa Bhojwani; Maryalice Stetler-Stevenson; Seth M Steinberg; Alan S Wayne; Ira Pastan
Journal:  Br J Haematol       Date:  2010-06-07       Impact factor: 6.998

10.  Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.

Authors:  Alan S Wayne; Robert J Kreitman; Harry W Findley; Glen Lew; Cynthia Delbrook; Seth M Steinberg; Maryalice Stetler-Stevenson; David J Fitzgerald; Ira Pastan
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.